Literature DB >> 5316059

Late endophthalmitis after filtering surgery.

J M Hattenhauer, M P Lipsich.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5316059     DOI： 10.1016/0002-9394(71)91215-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Trabeculectomy augmented with mitomycin C application under the scleral flap.

Authors:  S Beatty; T Potamitis; S Kheterpal; E C O'Neill
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

Review 2.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

3.  Toxicity and clearance of intravitreal cefotetan.

Authors:  W Philipp; K Schmid; H J Steiner; B Pümpel; F Allerberger; H P Aichberger; W Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  The experimental and clinical use of intravitreal antibiotics to treat bacterial and fungal endophthalmitis.

Authors:  G A Peyman; D W Vastine; H I Meisels
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

5.  Intravitreal oxacillin in experimental staphylococcal endophthalmitis.

Authors:  R T Kasbeer; G A Peyman
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-09-05

6.  Diagnostic pars plana vitrectomy report of a 21-year retrospective study.

Authors:  G N Palexas; W R Green; M F Goldberg; Y Ding
Journal:  Trans Am Ophthalmol Soc       Date:  1995

7.  Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.

Authors:  Makoto Araie; Shiroaki Shirato; Yoshio Yamazaki; Yoshiaki Kitazawa; Yasuo Ohashi
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

8.  Recurrent bleb infections.

Authors:  S Waheed; J M Liebmann; D S Greenfield; D C Ritterband; J A Seedor; M Shah; R Ritch
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.